Cargando…

Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments

Gradual degeneration and loss of dopaminergic neurons in the substantia nigra, pars compacta and subsequent reduction of dopamine levels in striatum are associated with motor deficits that characterize Parkinson’s disease (PD). In addition, half of the PD patients also exhibit frontostriatal-mediate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maiti, Panchanan, Manna, Jayeeta, Dunbar, Gary L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655877/ https://www.ncbi.nlm.nih.gov/pubmed/29090092 http://dx.doi.org/10.1186/s40035-017-0099-z

Ejemplares similares

Curcugreen Treatment Prevented Splenomegaly and Other Peripheral Organ Abnormalities in 3xTg and 5xFAD Mouse Models of Alzheimer’s Disease
por: Manna, Jayeeta, et al.
Publicado: (2021)

Molecular Chaperone Dysfunction in Neurodegenerative Diseases and Effects of Curcumin
por: Maiti, Panchanan, et al.
Publicado: (2014)

Use of Curcumin, a Natural Polyphenol for Targeting Molecular Pathways in Treating Age-Related Neurodegenerative Diseases
por: Maiti, Panchanan, et al.
Publicado: (2018)

Ameliorative Properties of Boronic Compounds in In Vitro and In Vivo Models of Alzheimer’s Disease
por: Maiti, Panchanan, et al.
Publicado: (2020)

Tetrahydrocurcumin Has Similar Anti-Amyloid Properties as Curcumin: In Vitro Comparative Structure-Activity Studies
por: Maiti, Panchanan, et al.
Publicado: (2021)

Combination treatment of berberine and solid lipid curcumin particles increased cell death and inhibited PI3K/Akt/mTOR pathway of human cultured glioblastoma cells more effectively than did individual treatments
por: Maiti, Panchanan, et al.
Publicado: (2019)

Comparative Neuroprotective Effects of Dietary Curcumin and Solid Lipid Curcumin Particles in Cultured Mouse Neuroblastoma Cells after Exposure to Aβ42
por: Maiti, Panchanan, et al.
Publicado: (2017)

Solid lipid curcumin particles provide greater anti-amyloid, anti-inflammatory and neuroprotective effects than curcumin in the 5xFAD mouse model of Alzheimer’s disease
por: Maiti, Panchanan, et al.
Publicado: (2018)

Retraction Note: Solid lipid curcumin particles provide greater anti-amyloid, anti-inflammatory and neuroprotective effects than curcumin in the 5xFAD mouse model of Alzheimer’s disease
por: Maiti, Panchanan, et al.
Publicado: (2023)

Role of Epigenetics in Stem Cell Proliferation and Differentiation: Implications for Treating Neurodegenerative Diseases
por: Srinageshwar, Bhairavi, et al.
Publicado: (2016)

CRISPR-Cas9 Mediated Gene-Silencing of the Mutant Huntingtin Gene in an In Vitro Model of Huntington’s Disease
por: Kolli, Nivya, et al.
Publicado: (2017)

Preservation of dendritic spine morphology and postsynaptic signaling markers after treatment with solid lipid curcumin particles in the 5xFAD mouse model of Alzheimer’s amyloidosis
por: Maiti, Panchanan, et al.
Publicado: (2021)

Correction to: Preservation of dendritic spine morphology and postsynaptic signaling markers after treatment with solid lipid curcumin particles in the 5xFAD mouse model of Alzheimer’s amyloidosis
por: Maiti, Panchanan, et al.
Publicado: (2022)

Retraction Note: Preservation of dendritic spine morphology and postsynaptic signaling markers after treatment with solid lipid curcumin particles in the 5xFAD mouse model of Alzheimer’s amyloidosis
por: Maiti, Panchanan, et al.
Publicado: (2023)

Solid Lipid Curcumin Particles Induce More DNA Fragmentation and Cell Death in Cultured Human Glioblastoma Cells than Does Natural Curcumin
por: Maiti, Panchanan, et al.
Publicado: (2017)

Silencing of the Mutant Huntingtin Gene through CRISPR-Cas9 Improves the Mitochondrial Biomarkers in an In Vitro Model of Huntington’s Disease
por: Dunbar, Gary L., et al.
Publicado: (2019)

Curcumin and Solid Lipid Curcumin Particles Induce Autophagy, but Inhibit Mitophagy and the PI3K-Akt/mTOR Pathway in Cultured Glioblastoma Cells
por: Maiti, Panchanan, et al.
Publicado: (2019)

Tart Cherry Extract and Omega Fatty Acids Reduce Behavioral Deficits, Gliosis, and Amyloid-Beta Deposition in the 5xFAD Mouse Model of Alzheimer’s Disease
por: Bowers, Zackary, et al.
Publicado: (2021)

Correction: Bowers et al. Tart Cherry Extract and Omega Fatty Acids Reduce Behavioral Deficits and Gliosis in the 5xFAD Mouse Model of Alzheimer’s Disease. Brain Sci. 2021, 11, 1423
por: Bowers, Zackary, et al.
Publicado: (2023)

Current surgical treatments for Parkinson's disease and potential therapeutic targets
por: Lee, Darrin J., et al.
Publicado: (2018)

Transplantation of mesenchymal stem cells overexpressing interleukin‐10 induces autophagy response and promotes neuroprotection in a rat model of TBI
por: Maiti, Panchanan, et al.
Publicado: (2019)

Liraglutide Has Anti-Inflammatory and Anti-Amyloid Properties in Streptozotocin-Induced and 5xFAD Mouse Models of Alzheimer’s Disease
por: Paladugu, Leela, et al.
Publicado: (2021)

Function of Macrophages in Disease: Current Understanding on Molecular Mechanisms
por: Zhang, Chunye, et al.
Publicado: (2021)

New awakenings: current understanding of sleep dysfunction and its treatment in Parkinson’s disease
por: Keir, Lindsay H. M., et al.
Publicado: (2019)

Depression in Patients with Parkinson’s Disease: Current Understanding of its Neurobiology and Implications for Treatment
por: Prange, Stéphane, et al.
Publicado: (2022)

Potential of animal models for advancing the understanding and treatment of pain in Parkinson’s disease
por: Buhidma, Yazead, et al.
Publicado: (2020)

Understanding the Potential of Genome Editing in Parkinson’s Disease
por: Arango, David, et al.
Publicado: (2021)

Solid Lipid Curcumin Particles Protect Medium Spiny Neuronal Morphology, and Reduce Learning and Memory Deficits in the YAC128 Mouse Model of Huntington’s Disease
por: Gharaibeh, Abeer, et al.
Publicado: (2020)

Genetic Rat Models of Parkinson's Disease
por: Welchko, Ryan M., et al.
Publicado: (2012)

LRRK2 inhibitors and their potential in the treatment of Parkinson’s disease: current perspectives
por: Atashrazm, Farzaneh, et al.
Publicado: (2016)

Recent advances in understanding and treatment of Parkinson’s disease
por: Tarakad, Arjun, et al.
Publicado: (2020)

Current understanding on molecular drug targets and emerging treatment strategy for novel coronavirus-19
por: Raj, Khadga, et al.
Publicado: (2021)

Current Approaches for Advancement in Understanding the Molecular Mechanisms of Mycotoxin Biosynthesis
por: Gallo, Antonia, et al.
Publicado: (2021)

Current approaches to the treatment of Parkinson’s disease
por: Jankovic, Joseph, et al.
Publicado: (2008)

Physics of zero- and one-dimensional nanoscopic systems
por: Karmakar, Sachindra, et al.
Publicado: (2007)

LRRK2 Targeting Strategies as Potential Treatment of Parkinson’s Disease
por: Wojewska, Dominika Natalia, et al.
Publicado: (2021)

Understanding the Involvement of microRNAs in Mitochondrial Dysfunction and Their Role as Potential Biomarkers and Therapeutic Targets in Parkinson’s Disease
por: Tryphena, Kamatham Pushpa, et al.
Publicado: (2023)

New Understanding on the Pathophysiology and Treatment of Constipation in Parkinson’s Disease
por: Xu, Jianli, et al.
Publicado: (2022)

Gastrointestinal Dysfunction in Parkinson’s Disease: Current and Potential Therapeutics
por: Han, Myat Noe, et al.
Publicado: (2022)

Current Understanding of the Genetics and Molecular Mechanisms Regulating Wood Formation in Plants
por: Kim, Min-Ha, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_79mu3i5gjk7d3j7q9pem1h2bp2